Related Experiment Video
Updated: Apr 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Fungal infections in intestinal and multivisceral transplant recipients
Diana F Florescu1, Uriel Sandkovsky
1aTransplant Infectious Diseases Program, Division of Infectious Diseases bTransplant Surgery Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Purpose Of Review:
Patients who undergo intestinal and multivisceral transplantation are at increased risk for infectious complications. Fungal infections are major causes of morbidity and mortality in these patients. The current review highlights key diagnostic and management issues in this population.
Recent Findings:
Invasive infections caused by Candida spp. remain the most common invasive fungal infections in intestinal and multivisceral transplant recipients. Aspergillus is an emerging pathogen but data are limited to case reports or case series. Other fungi including the mucorales, Cryptococcus and endemic mycoses are emerging pathogens but data regarding incidence and timing of disease in intestinal and multivisceral transplant recipients are lacking.
Summary:
Invasive candidiasis is the most common fungal infection in patients with intestinal and multivisceral transplants. Experience for diagnosis and management comes from case series and single centers. Diagnosis and management of infections caused by other pathogens such as Aspergillus, Cryptococcus, Mucor, and endemic mycoses is usually extrapolated from other solid organ transplant recipients.
Insights
Fungal infections, particularly Candida, are common and serious complications after intestinal and multivisceral transplantation. Management strategies for rarer fungal pathogens require further investigation in this vulnerable patient group.
Area of Science:
- Transplantation immunology
- Infectious diseases
- Mycology
Background:
- Intestinal and multivisceral transplantation carry a high risk of infectious complications.
- Fungal infections represent a significant cause of morbidity and mortality in these immunocompromised patients.
Purpose of the Study:
- To review key diagnostic and management issues of fungal infections in intestinal and multivisceral transplant recipients.
- To highlight the current understanding of common and emerging fungal pathogens in this population.
Main Methods:
- Literature review focusing on diagnostic and management strategies.
- Analysis of case reports, case series, and single-center experiences.
- Synthesis of data from other solid organ transplant recipients for less common pathogens.
Main Results:
- Invasive candidiasis is the most frequent fungal infection in this patient cohort.
- Aspergillus, mucorales, Cryptococcus, and endemic mycoses are emerging fungal pathogens, but data are limited.
- Current diagnostic and management experience is largely derived from case studies and extrapolated from other transplant types.
Conclusions:
- Invasive candidiasis is the primary fungal threat in intestinal and multivisceral transplant recipients.
- Diagnosis and treatment protocols for less common fungal infections are often based on data from other solid organ transplant populations.
- Further research is needed to establish specific guidelines for emerging fungal pathogens in this unique patient group.
Related Concept Videos
Fungal Phylum Microsporidia
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Antifungal Agents
Kidney Transplant II: Surgical Procedure
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

